Pfizer Inc. (PFE) has agreed to pay $190 million to settle a lawsuit involving Neurontin, the drug maker's epilepsy drug, Reuters reported Monday on its website, citing court documents.

Plaintiffs in the suit, filed in 2002, had claimed Pfizer delayed generic versions of the drug from the market.

Full story at: www.reuters.com/article/2014/04/21/usa-antitrust-pfizer-idUSL2N0ND17020140421

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Pfizer Charts.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Pfizer Charts.